KRPIA has launched its new board of directors for the 2024 New Year.

The Korean Research-based Pharmaceutical Industry Association (KRPIA) has recently announced its new board of directors (BOD).

The new BOD stands out as it is primarily made up of Korean members.

Among the 13 BOD members, which includes KRPIA chairman Dong-Wook Oh (CEO of Pfizer Korea), only two are foreign nationals, making up 85% of the board as Korean members.

Because multinational pharmaceutical companies appointing Koreans as CEOs of their Korean branch instead of foreign nationals, it has likely led to the BOD members consisting primarily of Korean members.

CE